← Leaderboards

Lynn M Schnapp

Mount Sinai School Of Medicine Of Nyu

Google Scholar ↗PubMed ↗ORCID ↗

$6,284,865

Attributed

$9,143,490

Total exposure

9

Grants

5

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.6M · FY2005–20

$2M$1.5M$1M$500K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

Funding mix

By agency

NIH$9,143,490 · 9

By mechanism

R01$7,234,455 · 5

K24$774,095 · 1

R56$683,614 · 1

R21$426,326 · 1

R13$25,000 · 1

Top collaborators

Most similar at Mount Sinai School Of Medicine Of Nyu

Same institution · by research overlap

Others in their field

Top investigators on “Lung”

Sonia M Thomas · Research Triangle Institute$701,865,642
Tracy L Nolen · Research Triangle Institute$474,487,152
David Heimbrook · Leidos Biomedical Research, Inc.$372,040,227
Chanza Baytop · Westat, Inc.$271,217,917
Richard K. Wilson · Washington University$201,818,043
Walter John Curran · Thomas Jefferson University$112,093,071

Research focus

LungProteomicsPathway InteractionsLung InjuryInsightProgramsHiv InfectionsBronchoalveolar Lavage FluidProteinsDiagnosisOrganInflammationResearch PersonnelLung DiseasesCellsBasePathogenesisInfectionMorbidity - Disease RateMethodologyEnvironmentBiological MarkersNovel TherapeuticsSeverities

Grant awards (28)

Role of pericytes in scleroderma skin and lung fibrosis$440,389

R01 · FY2020 · HL · contact PI

Role of pericytes in scleroderma skin and lung fibrosis$522,531

R01 · FY2019 · HL · contact PI

HIV and Emphysema _ Role of Pulmonary Vascular Dysfunction$730,982

R01 · FY2018 · HL

Role of pericytes in scleroderma skin and lung fibrosis$522,531

R01 · FY2018 · HL · contact PI

Role of pericytes in scleroderma skin and lung fibrosis$521,185

R01 · FY2017 · HL · contact PI

HIV and Emphysema _ Role of Pulmonary Vascular Dysfunction$698,438

R01 · FY2016 · HL

HIV and Emphysema _ Role of Pulmonary Vascular Dysfunction$678,741

R01 · FY2015 · HL

HIV and Emphysema _ Role of Pulmonary Vascular Dysfunction$690,967

R01 · FY2014 · HL

Endothelial mechanisms of impaired lung gas exchange by HIV$572,938

R56 · FY2014 · HL

Impact of HIV Infection on Cellular Senescence and Potential Role in COPD Pathoge$219,266

R21 · FY2014 · HL · contact PI

Endothelial mechanisms of impaired lung gas exchange by HIV$110,676

R56 · FY2014 · HL

Impact of HIV Infection on Cellular Senescence and Potential Role in COPD Pathoge$177,905

R21 · FY2013 · HL · contact PI

Impact of HIV infection on Cellular Senescence and potential role in COPD pathoge$29,155

R21 · FY2013 · HL · contact PI

Proteomic-based Approach to Ventilator Associated Pneumonia$164,728

K24 · FY2011 · HL · contact PI

2011 Lung Development, Injury and Repair Gordon Research Conference$25,000

R13 · FY2011 · HL · contact PI

Proteomic-based Approach to Ventilator Associated Pneumonia$161,503

K24 · FY2010 · HL · contact PI

Matrix remodeling in the lung during HIV infection$369,790

R01 · FY2009 · HL · contact PI

Proteomic-based Approach to Ventilator Associated Pneumonia$158,371

K24 · FY2009 · HL · contact PI

Matrix remodeling in the lung during HIV infection$369,790

R01 · FY2008 · HL · contact PI

Proteomic-based Approach to Ventilator Associated Pneumonia$155,332

K24 · FY2008 · HL · contact PI

Matrix remodeling in the lung during HIV infection$369,790

R01 · FY2007 · HL · contact PI

Proteomic-based Approach to Ventilator Associated Pneumonia$134,161

K24 · FY2007 · HL · contact PI

Matrix remodeling in the lung during HIV infection$379,614

R01 · FY2006 · HL · contact PI

Matrix remodeling in the lung during HIV infection$388,750

R01 · FY2005 · HL

Proteomics-based approach to ARDS$124,221

R01 · FY2004 · HL

Proteomics-based approach to ARDS$137,918

R01 · FY2003 · HL

LYMPHOCYTE ADHESION AND HIV ACTIVATION IN THE LUNG$270,125

R01 · FY2000 · HL

LYMPHOCYTE ADHESION AND HIV ACTIVATION IN THE LUNG$18,693

R01 · FY2000 · HL